Overview Dividends

(ALTO) Alto Ingredients - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0215131063

Ethanol, Alcohol, Ingredients, Feed, Corn

Oil & Gas Refining & Marketing
Market Cap in USD: 223m

IPO / Inception: 2005-03-24
Return 12m vs S&P 500: 16.4%

EPS (Earnings per Share)

EPS CAGR: -23.03%
EPS Trend: -20.2%

Last SUE: 2.75
Qual. Beats: 1

Revenue

Rev. CAGR: -11.77%
Rev. Trend: -92.4%

Last SUE: 0.37
Qual. Beats: 0

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	71.3%
Value at Risk 5%th	94.3%
Relative Tail Risk	-19.66%

Reward TTM
Sharpe Ratio	0.69
Alpha	23.93
CAGR/Max DD	-0.10

Character TTM
Hurst Exponent	0.935
Beta	0.660
Beta Downside	1.103

Drawdowns 3y
Max DD	84.15%
Mean DD	54.78%
Median DD	63.82%

Description: ALTO Alto Ingredients November 30, 2025

Alto Ingredients, Inc. (NASDAQ: ALTO) manufactures and markets specialty alcohols, renewable fuels, and essential feed ingredients across three operating segments-Marketing & Distribution, Pekin Campus Production, and Western Production. Its product slate spans mouth-wash and hand-sanitizer alcohols, grain-neutral spirits for beverages and vinegar, corn-germ oil for renewable diesel, and a range of animal-feed proteins, positioning the company at the intersection of consumer, industrial, and agricultural markets.

Key operating metrics (FY 2023) show revenue of roughly **$1.2 billion**, an adjusted EBITDA margin near **13 %**, and ethanol output of **≈ 800 million gallons**-approximately 30 % of which is sold as fuel-grade ethanol under the Renewable Fuel Standard (RFS). The business’s earnings are sensitive to two primary drivers: (1) **RIN (Renewable Identification Number) credit prices**, which have averaged $1.90 per RIN in 2023, and (2) **corn feedstock costs**, which have hovered around $5.80 per bushel, affecting both ethanol margins and the cost of corn-derived ingredients. A diversified product mix helps mitigate exposure to any single commodity price swing.

For a deeper, data-driven look at ALTO’s valuation and peer benchmarks, the ValueRay platform provides a concise, analytics-focused overview.

Piotroski VR‑10 (Strict, 0-10) 0.5

Net Income (-50.2m TTM) > 0 and > 6% of Revenue (6% = 55.3m TTM)

FCFTA -0.03 (>2.0%) and ΔFCFTA -3.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 11.76% (prev 9.98%; Δ 1.78pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.02 (>3.0%) and CFO -6.08m > Net Income -50.2m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 3.56 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (74.4m) change vs 12m ago 0.79% (target <= -2.0% for YES)

Gross Margin 1.99% (prev 0.86%; Δ 1.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 228.9% (prev 240.2%; Δ -11.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -3.62 (EBITDA TTM -13.3m / Interest Expense TTM 10.8m) >= 6 (WARN >= 3)

Altman Z'' -11.06

(A) 0.28 = (Total Current Assets 150.9m - Total Current Liabilities 42.4m) / Total Assets 388.5m

(B) -2.15 = Retained Earnings (Balance) -833.6m / Total Assets 388.5m

warn (B) unusual magnitude: -2.15 — check mapping/units

(D) -4.99 = Book Value of Equity -828.5m / Total Liabilities 166.1m

Total Rating: -11.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 20.40

1. Piotroski 0.50pt

2. FCF Yield -3.23%

3. FCF Margin -1.09%

4. Debt/Equity 0.54

5. Debt/Ebitda -6.55

6. ROIC - WACC (= -17.59)%

7. RoE -23.09%

8. Rev. Trend -92.38%

9. EPS Trend -20.24%

What is the price of ALTO shares?

As of January 08, 2026, the stock is trading at USD 2.40 with a total of 1,006,891 shares traded.
Over the past week, the price has changed by -16.67%, over one month by +1.27%, over three months by +116.22% and over the past year by +37.93%.

Is ALTO a buy, sell or hold?

Alto Ingredients has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy ALTO.

Strong Buy: 1
Buy: 1
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ALTO price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	4.3	77.1%
Analysts Target Price	4.3	77.1%
ValueRay Target Price	2.6	8.7%

ALTO Fundamental Data Overview January 03, 2026

Market Cap USD = 222.9m (222.9m USD * 1.0 USD.USD)
P/E Forward = 17.9856
P/S = 0.2417
P/B = 1.0016
Beta = 0.518
Revenue TTM = 922.3m USD
EBIT TTM = -39.2m USD
EBITDA TTM = -13.3m USD
Long Term Debt = 100.6m USD (from longTermDebt, last quarter)
Short Term Debt = 5.14m USD (from shortTermDebt, last quarter)
Debt = 119.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 87.2m USD (from netDebt column, last quarter)
Enterprise Value = 310.1m USD (222.9m + Debt 119.7m - CCE 32.5m)
Interest Coverage Ratio = -3.62 (Ebit TTM -39.2m / Interest Expense TTM 10.8m)
FCF Yield = -3.23% (FCF TTM -10.0m / Enterprise Value 310.1m)
FCF Margin = -1.09% (FCF TTM -10.0m / Revenue TTM 922.3m)
Net Margin = -5.44% (Net Income TTM -50.2m / Revenue TTM 922.3m)
Gross Margin = 1.99% ((Revenue TTM 922.3m - Cost of Revenue TTM 904.0m) / Revenue TTM)
Gross Margin QoQ = 9.75% (prev -0.89%)
Tobins Q-Ratio = 0.80 (Enterprise Value 310.1m / Total Assets 388.5m)
Interest Expense / Debt = 2.34% (Interest Expense 2.80m / Debt 119.7m)
Taxrate = 6.66% (946.0k / 14.2m)
NOPAT = -36.6m (EBIT -39.2m * (1 - 6.66%)) [loss with tax shield]
Current Ratio = 3.56 (Total Current Assets 150.9m / Total Current Liabilities 42.4m)
Debt / Equity = 0.54 (Debt 119.7m / totalStockholderEquity, last quarter 222.4m)
Debt / EBITDA = -6.55 (negative EBITDA) (Net Debt 87.2m / EBITDA -13.3m)
Debt / FCF = -8.71 (negative FCF - burning cash) (Net Debt 87.2m / FCF TTM -10.0m)
Total Stockholder Equity = 217.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -12.92% (Net Income -50.2m / Total Assets 388.5m)
RoE = -23.09% (Net Income TTM -50.2m / Total Stockholder Equity 217.3m)
RoCE = -12.33% (EBIT -39.2m / Capital Employed (Equity 217.3m + L.T.Debt 100.6m))
RoIC = -11.33% (negative operating profit) (NOPAT -36.6m / Invested Capital 322.9m)
WACC = 6.26% (E(222.9m)/V(342.6m) * Re(8.45%) + D(119.7m)/V(342.6m) * Rd(2.34%) * (1-Tc(0.07)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.99%
Fair Price DCF = unknown (Cash Flow -10.0m)
EPS Correlation: -20.24 | EPS CAGR: -23.03% | SUE: 2.75 | # QB: 1
Revenue Correlation: -92.38 | Revenue CAGR: -11.77% | SUE: 0.37 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.12 | Chg30d=+0.030 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.25 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=-38.9% | Growth Revenue=+8.1%

Additional Sources for ALTO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle